It’s not just Depo-Provera — study links 5 more birth control drugs to brain tumor risk
Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, known as a meningioma, while the contraceptive’s maker, Pfizer, faces hundreds of lawsuits claiming that it was aware of the potential risks. The brand name for depot medroxyprogesterone acetate (DMPA), Depo-Provera, contains the synthetic progestin hormone and is used by roughly 1 in 4 … Read more